Cost-Effectiveness Analysis of Three Quinolones for Respiratory Tract Infection
- VernacularTitle:3种喹诺酮类药物治疗上呼吸道感染成本-效果分析
- Author:
Xiaoling CHEN
- Publication Type:Journal Article
- Keywords:
Respiratory tract infection;
Quinolones;
Cost-effectiveness analysis
- From:
China Pharmacy
2001;0(08):-
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To evaluate the pharmacoeconomic effectiveness of three quinolones for respiratory tract infections.METHODS:A retrospective study was conducted in which a total of 94 cases with respiratory tract infection were randomly to receive levofloxacin(Group A),ciprofloxacin(Group B) or moxifloxacin(Group C).The therapeutic effects were monitored and the cost-effectiveness analysis was performed on the three treatment schemes.RESULTS:The costs of the three groups were 397.60,1 131.90,and 2 255.40 yuan,respectively;the clinical effective rates were 73.53%,85.71% and 93.75%,respectively(P
